Genetic deletion or pharmacological inhibition of NOX2 and NOX4 reduces brain tissue damage and improves neurological outcomes following hemorrhagic stroke (Shin et al., 2002; Tang et al., 2005). The gene discussed is NOX4; the disease is hemorrhagic stroke.